CAF-DCF is a Belgian company specialized in the commercialization of plasma derived medicines. They have long term expertise in life-saving products for rare and life-threatening diseases in three therapeutic domains : immunology, intensive care and hemostasis.
Their driving values are :
- Ethical commitment
- Dedication to Belgian healthcare services
- Safety of their products and of patients using them
The use of blood plasma drawn from volunteer donors and the preparation of products intended to save patients are the cornerstone of their "human-to-human approach".
CAF-DCF is controlled by the French biopharmaceutical group LFB. The company has historically been founded by the Belgian Red Cross and has a 40 years history of ethical product development , production and commercialization in the field of plasma derived medicines.